EpirubicinAntibiotics, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideFluorouracilBreast NeoplasmsDrug Administration ScheduleTreatment OutcomePaclitaxelTaxoidsRazoxaneChemotherapy, AdjuvantCisplatinDoxorubicinDeoxycytidineDisease-Free SurvivalNeoadjuvant TherapyDose-Response Relationship, DrugGranulocyte Colony-Stimulating FactorAnthracyclinesInfusions, IntravenousVinblastineSurvival AnalysisMethotrexateAlopeciaSurvival RateAntineoplastic AgentsNeutropeniaProlyl HydroxylasesIfosfamideHematologic DiseasesNeoplasm MetastasisNeoplasm StagingStomach NeoplasmsNauseaCombined Modality TherapyLeukopeniaVomitingFollow-Up StudiesAdenocarcinomaProspective StudiesTime FactorsNaphthacenesReceptor, erbB-2Drug Therapy, CombinationMaximum Tolerated Dose